fetching data ...

AB0796 (2024)
KLRB1 EXPRESSION SIGNIFIES CD4+ T CELL ACTIVATION AND IS HEIGHTENED IN PRIMARY SJÖGREN’S SYNDROME PATIENTS
Keywords: Biomarkers, Cytokines and Chemokines, Adaptive immunity
C. Liu1, Z. Zhang2, A. Bahabayi2, P. Wang3
1Peking University People‘s Hospital, Departmement of Clinical Laboratory, Beijing, China
2Peking University People‘s Hospital, Department of Clinical Laboratory, Beijing, China
3Peking University Health Science Center, Department of Immunology, NHC Key Laboratory of Medical Immunology (Peking University), School of Basic Medical Sciences, Beijing, China

Background: T cells play a pivotal role in primary Sjogren’s syndrome (pSS), necessitating a comprehensive understanding for targeted therapies. While KLRB1 is associated with autoimmune diseases, its role in pSS T cells is still unclear.


Objectives: The objective of this study was to explore the function of KLRB1 in human CD4+ T cells and uncover its relevance in pSS.


Methods: This study collected peripheral blood samples from 37 healthy controls and 44 pSS patients, using RNA-Seq data from pSS patient PBMCs to analyze KLRB1 expression in T cells. Flow cytometry was utilized to determine KLRB1-expressing T lymphocyte subsets in pSS patients and healthy controls. CD25, Ki-67, cytokine secretion, and chemokine receptor expression were compared between CD4+KLRB1+ and CD4+KLRB1- T cells, with correlation analysis conducted between KLRB1-related T cell subsets and clinical indicators. ROC curves were employed to explore KLRB1’s diagnostic potential for pSS.


Results: Upon T cell activation, KLRB1 expression is notably increased, accompanied by significantly elevated levels of Ki-67 and CD25 in CD4+KLRB1+ T cells in comparison to CD4+KLRB1- T cells. Furthermore, CD4+KLRB1+ T cells exhibit heightened secretion of pro-inflammatory cytokines including IL-17A, IL-21, IL-22, and IFN-γ upon stimulation. Additionally, there is a significantly higher presence of CCR5+, CCR2+, CX3CR1+, CCR6+, and CXCR3+ cells within CD4+KLRB1+ T cells as opposed to CD4+KLRB1- T cells. Importantly, KLRB1 expression in CD4+ T cells is significantly elevated in pSS patients compared to healthy controls (HCs), and this upregulation of KLRB1 correlates significantly with clinical disease indicators in pSS patients.


Conclusion: KLRB1 serves as a distinctive marker of CD4+ T cell activation phenotype, and its heightened expression within CD4+ T cells of pSS patients implies its potential role in pSS pathogenesis and its potential as a supplementary diagnostic indicator for pSS.


REFERENCES: NIL.


Acknowledgements: This research was supported by grants from National Natural Science Foundation of China (82271755, 31972899, 81871230).


Disclosure of Interests: None declared.


DOI: 10.1136/annrheumdis-2024-eular.2489
Keywords: Biomarkers, Cytokines and Chemokines, Adaptive immunity
Citation: , volume 83, supplement 1, year 2024, page 1692
Session: Sjön`s syndrome (Publication Only)